Farnesyltransferase inhibitor (L-744,832) restores TGF-β type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2-Reference-Cited by-同舟云学术

Farnesyltransferase inhibitor (L-744,832) restores TGF-β type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2

Published:2002-11 Issue:51 Volume:21 Page:7883-7890
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Alcock Rachael A,Dey Swatee,Chendil Damodaran,Inayat Mohammed S,Mohiuddin Mohammed,Hartman George,Chatfield Lee K,Gallicchio Vincent S,Ahmed Mansoor M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1205948.pdf

Reference48 articles.

1. Adnane J, Bizouarn FA, Chen Z, Ohkanda J, Hamilton AD, Munoz-Antonia T, Sebti SM . 2000 Oncogene 19: 5525–5533

2. Ahmed MM, Alcock RA, Chendil D, Dey S, Das A, Venkatasubbarao K, Mohiuddin M, Sun L, Strodel WE, Freeman JW . 2002 J. Biol. Chem. 277: 2234–2246

3. Ahmed MM, Sells SF, Venkatasubbarao K, Fruitwala SM, Muthukkumar S, Harp C, Mohiuddin M, Rangnekar VM . 1997 J. Biol. Chem. 272: 33056–33061

4. Alexandrow MG, Moses HL . 1995 Cancer Res. 55: 1452–1457

5. Bae HW, Geiser AG, Kim D, Chung MT, Burmester JK, Sporn MB, Roberts AB, Kim SJ . 1995 J. Biol. Chem. 270: 29460–29468

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic resistance of pancreatic cancer: Roadmap to its reversal;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-01

2. Role of Par-4 in Radiation Sensitivity of Cancer;Tumor Suppressor Par-4;2021

3. Post-translational modification of KRAS: potential targets for cancer therapy;Acta Pharmacologica Sinica;2020-10-21

4. Targets for improving tumor response to radiotherapy;International Immunopharmacology;2019-11

5. H‐ ras deletion protects against angiotensin II–induced arterial hypertension and cardiac remodeling through protein kinase G‐Iβ pathway activation;The FASEB Journal;2018-01-04